Mereo BioPharma (MREO) Other financing activities (2025)
Mereo BioPharma (MREO) posted quarterly Other financing activities of $487000.0 for Q1 2025.
Mereo BioPharma (MREO) Other financing activities (2025) Analysis & Trends
Mereo BioPharma (MREO) has reported Other financing activities for 1 consecutive years, with $487000.0 the latest figure, recorded in Q1 2025.
- Quarterly Other financing activities changed N/A year-over-year to $487000.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $487000.0 (changed N/A YoY) and the FY2025 annual result came in at $487000.0, changed N/A from the prior year.
- Other financing activities held at $487000.0 in Q1 2025 per MREO's latest filing.
- Over the last five years, Other financing activities for MREO reached as high as $487000.0 in Q1 2025 and fell as low as $487000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 487,000.00 |
| Mar 31, 2025 | 487,000.00 |